Arcus Biosciences, Inc. Shares Outstanding (Cover Page)
Arcus Biosciences, Inc. (RCUS) had Shares Outstanding (Cover Page) of 127.33 million shares as of 2026-07-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-30: Entity Common Stock, Shares Outstanding 127.33M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 125.77M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 125.35M shares.
- 2025-10-23: Entity Common Stock, Shares Outstanding 107.97M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 127.33M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 125.77M shares 10-Q · filed 2026-05-05 |
| 2026-02-19 | 125.35M shares 10-K · filed 2026-02-25 |
| 2025-10-23 | 107.97M shares 10-Q · filed 2025-10-28 |
| 2025-08-01 | 106.43M shares 10-Q · filed 2025-08-06 |
| 2025-05-01 | 105.89M shares 10-Q · filed 2025-05-06 |
| 2025-02-19 | 105.84M shares 10-K · filed 2025-02-25 |
| 2024-10-30 | 91.51M shares 10-Q · filed 2024-11-06 |
| 2024-08-01 | 91.43M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 90.95M shares 10-Q · filed 2024-05-08 |
| 2024-02-14 | 90.86M shares 10-K · filed 2024-02-21 |
| 2023-11-01 | 74.86M shares 10-Q · filed 2023-11-07 |
| 2023-08-02 | 74.50M shares 10-Q · filed 2023-08-07 |
| 2023-05-03 | 73.11M shares 10-Q · filed 2023-05-09 |
| 2023-02-17 | 73.01M shares 10-K · filed 2023-02-28 |
| 2022-10-28 | 72.41M shares 10-Q · filed 2022-11-02 |
| 2022-07-29 | 72.16M shares 10-Q · filed 2022-08-03 |
| 2022-04-29 | 71.72M shares 10-Q · filed 2022-05-09 |
| 2022-02-12 | 71.06M shares 10-K · filed 2022-02-23 |
| 2021-10-29 | 70.25M shares 10-Q · filed 2021-11-08 |
| 2021-07-30 | 71.39M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 71.00M shares 10-Q · filed 2021-05-05 |
| 2021-02-12 | 70.88M shares 10-K · filed 2021-02-25 |
| 2020-10-31 | 64.92M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 64.91M shares 10-Q · filed 2020-08-06 |
| 2020-04-30 | 46.05M shares 10-Q · filed 2020-05-05 |
| 2020-02-28 | 45.97M shares 10-K · filed 2020-03-05 |
| 2019-10-30 | 45.86M shares 10-Q · filed 2019-11-05 |
| 2019-07-30 | 45.85M shares 10-Q · filed 2019-08-06 |
| 2019-04-29 | 44.54M shares 10-Q · filed 2019-05-02 |
| 2019-03-01 | 44.53M shares 10-K · filed 2019-03-05 |
| 2018-11-01 | 44.45M shares 10-Q · filed 2018-11-08 |
| 2018-08-01 | 44.46M shares 10-Q · filed 2018-08-06 |
| 2018-05-01 | 44.45M shares 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |